Parallax Volatility Advisers, L.P. Altimmune, Inc. Put Options Transaction History

Parallax Volatility Advisers, L.P.

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	BUY	$10.67 - $22.41 $104,566 - $219,618	9,800 New	9,800 $125,000
Q3 2021 Nov 15, 2021	BUY	$8.43 - $16.81 $580,827 - $1.16 Million	68,900 New	68,900 $779,000
Q2 2021 Aug 16, 2021	SELL	$9.85 - $16.46 $492,500 - $823,000	-50,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$7.84 - $14.22 $392,000 - $711,000	50,000 New	50,000 $564,000

208

39.5M

1.94M

1.38M

Ticker ALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,025,300
Market Cap $315M
Description
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatit...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.